Skip to main content
. 2017 Aug 17;8(41):70299–70309. doi: 10.18632/oncotarget.20313

Figure 8. Effect of standardized primary gross volume for lymph nodes (SGTVnd) on local relapse-free survival.

Figure 8

HHS Vulnerability Disclosure